ProblemBiotech

Diagnostics and Biomarkers: research question

Which diagnostics and biomarkers show reproducible clinical utility across populations and care settings?

approveddraft

Reviewed question

Bottlenecks

  • External validation
  • Bias across cohorts
  • Workflow adoption

Entry points

  • Validation studies
  • Trial records
  • Regulatory evidence

Evidence summary

Track studies and registry updates with validation and population details. Evidence candidates are attached from recent source-backed outputs in this topic.

SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing Institute

Relationship evidence

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... (NCT05621291)

ADDRESSES PROBLEMincoming82% confidence

Timeline